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DVL3 Alleles Resulting
in a 1 Frameshift of the Last Exon
Mediate Autosomal-Dominant Robinow Syndrome
Janson J. White,1,11 Juliana F. Mazzeu,2,3,11 Alexander Hoischen,4 Yavuz Bayram,1 Marjorie Withers,1
Alper Gezdirici,5 Virginia Kimonis,6 Marloes Steehouwer,4 Shalini N. Jhangiani,7 Donna M. Muzny,7
Richard A. Gibbs,1,7 Baylor-Hopkins Center for Mendelian Genomics, Bregje W.M. van Bon,4
V. Reid Sutton,1,8 James R. Lupski,1,7,8,9 Han G. Brunner,4,10,* and Claudia M.B. Carvalho1,*
Robinow syndrome is a rare congenital disorder characterized by mesomelic limb shortening, genital hypoplasia, and distinctive facial
features. Recent reports have identified, in individuals with dominant Robinow syndrome, a specific type of variant characterized by
being uniformly located in the penultimate exon of DVL1 and resulting in a 1 frameshift allele with a premature termination codon
that escapes nonsense-mediated decay. Here, we studied a cohort of individuals who had been clinically diagnosed with Robinow syn-
drome but who had not received a molecular diagnosis from variant studies of DVL1, WNT5A, and ROR2. Because of the uniform loca-
tion of frameshift variants inDVL1-mediated Robinow syndrome and the functional redundancy of DVL1, DVL2, and DVL3, we elected
to pursue direct Sanger sequencing of the penultimate exon of DVL1 and its paralogs DVL2 and DVL3 to search for potential disease-
associated variants. Remarkably, targeted sequencing identified five unrelated individuals harboring heterozygous, de novo frameshift
variants in DVL3, including two splice acceptor mutations and three 1 bp deletions. Similar to the variants observed in DVL1-mediated
Robinow syndrome, all variants in DVL3 result in a 1 frameshift, indicating that these highly specific alterations might be a common
cause of dominant Robinow syndrome.Here, we review the current knowledge of these peculiar variant alleles inDVL1- andDVL3-medi-
ated Robinow syndrome and further elucidate the phenotypic features present in subjects with DVL1 and DVL3 frameshift mutations.Robinow syndrome is a genetically heterogeneous disorder
that can segregate as either an autosomal-dominant (DRS1
[MIM: 180700]) or an autosomal-recessive (RRS [MIM:
268310]) trait. DRS can result from hypomorphic muta-
tions in WNT5A1,2 (MIM: 164975), whereas RRS is caused
by biallelic loss-of-function variants in ROR23,4 (MIM:
602337). The original clinical description of Robinow syn-
drome included mesomelia, normal intellect, genital hy-
poplasia, and distinctive facial features comprising frontal
bossing, prominent eyes, and a depressed nasal bridge,
which are collectively referred to as a ‘‘fetal face.’’5
Recently, studies on cohorts of individuals presenting
with DRS have identified an intriguing mutational mecha-
nism, uniformly located frameshift mutations within
DVL1 (MIM: 601365), as a cause of DRS6,7 (DRS2 [MIM:
616331]). The nature of these rare variants is remarkable:
all cluster within the penultimate exon, consistently
resulting in a 1 frameshift, and all share an identical pre-
mature termination codon. The mutant alleles are pre-
dicted to escape nonsense-mediated decay8 (NMD) and
thus result in a protein product containing a mutant C ter-
minus that is rich in proline, highly basic, and greater than
100 amino acids in length.6,7 However, a large fraction of1Department of Molecular and Human Genetics, Baylor College of Medicine, H
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The Ameindividuals with DRS remain without an etiologic molecu-
lar diagnosis; they do not have variants in genes known to
be associated with Robinow syndrome. It is noteworthy
that all of the current known genic causes of Robinow
syndrome, including heterozygous hypomorphic alleles
in WNT5A, biallelic loss-of-function variants in ROR2,
and frameshifts in DVL1, occur within genes involved
in non-canonical Wnt signaling. WNT5A acts as an
extracellular soluble ligand that is recognized by ROR2,
and together they employ the dishevelled (DVL) family
of proteins to further transduce the non-canonical
signal.9
The complexity of human development requires coordi-
nation of distinct cellular signaling pathways. Core path-
ways, including hedgehog, TGF-b, and Wnt signaling,
have been studied extensively. Wnt-b-catenin signaling
consists of highly conserved machinery that coordinates
cell fate, proliferation, and differentiation during de-
velopment and tissue homeostasis.10,11 Non-canonical,
b-catenin-independent Wnt signaling is involved in
orchestrating cell migration and tissue morphogenesis,
including convergent-extension movements in verte-
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Figure 1. Locations of All Currently Described Variants Resulting in DVL1-Mediated Robinow Syndrome
(A) Depiction of the resulting mutant transcript in BAB8062. Black represent regions identical to the wild-type DVL1, and red indicates
the mutant coding region.
(B) Locations of all variants currently described in the literature. Orange indicates nucleotides deleted in individuals reported by Bunn
et al.,6 green represents those from White et al.,7 and yellow indicates those in BAB8062, reported here. All the variants are located
within a stretch of ~110 nucleotides in the penultimate exon, and all are deletions that result in a 1 frameshift.three human homologs of dishevelled,DVL1,DVL2 (MIM:
602151), and DVL3 (MIM: 601368), are core components
in the correct routing and transmission of canonical and
non-canonical Wnt signals, most likely by acting in large
multiprotein complexes.14,15 Collectively, Robinow syn-
drome appears to be a result of dysregulation in the
WNT5A-ROR2-DVL pathway. Because a majority of indi-
viduals with Robinow syndrome do not receive a molecu-
lar diagnosis, we hypothesized that affected individuals
have mutations residing in distinct genes within this
branch of the non-canonical Wnt pathway, including the
dishevelled human paralogs, DVL1, DVL2, and DVL3.
Because of the uniform location of disease-associated var-
iants inDVL1-mediatedRobinowsyndromeand theknowl-
edge that DVL1, DVL2, and DVL3 share 59%–67% amino
acid homology,16,17 we elected to perform direct Sanger
sequencing of the penultimate and final exons of DVL1,
DVL2, and DVL3 in a cohort of 34 individuals referred to
Radboud University Medical Center for diagnostic testing.
All individuals had received a clinical diagnosis of possible
Robinow syndrome by a clinical geneticist. DNA was
obtained from the subjects and unaffected familymembers
after they provided written informed consent. This study
was approvedby theRadboudUniversityMedicalCenter re-
view board and by the institutional review board at Baylor
College of Medicine (protocol no. H-29697). Individuals
were not pre-selected for similarity of their traits or possible
modes of inheritance. From this cohort, 24 individuals had
been screened for variants in ROR2, but no candidate554 The American Journal of Human Genetics 98, 553–561, March 3variants were identified.WNT5A had been tested in one in-
dividual. Dominant inheritance was suspected for 16 indi-
viduals, and recessive inheritance was suspected in one
individual. The mode of inheritance was undetermined
for the remaining individuals. One individual from this
large cohort, 015902, was found to have a frameshift dele-
tion within the final exon of DVL3.
To confirm and assess the contribution of dishevelled to
the phenotype, we then Sanger sequenced the penultimate
and final exons of DVL1, DVL2, and DVL3 from our
in-house database of subjects (n ¼ 17) with Robinow
syndrome. These subjects were ascertained on the basis of
clinical similarity to those with DVL1-mediated Robinow
syndrome. Of the ten affected individuals, two were
screened for variants in WNT5A, and two were screened
for variants in ROR2. In concordance with the observations
underlying DVL1-mediated Robinow syndrome,7 one
affected individual had a frameshift in the penultimate
exon of DVL1 (Figure 1). Remarkably, four additional indi-
viduals harbored variants in DVL3, including two frame-
shifts and two splice acceptor mutations affecting the
penultimate or last exon (Figure 2). In total, one individual
with a variant inDVL1 and five individuals with variants in
DVL3 were identified from the above-described approach.
All DVL1 and DVL3 variants identified from Sanger
sequencing were annotated and analyzed with conceptual
translation from Mutalyzer version 2.0.8.18
Individual BAB8062,who is of Turkish ancestry, harbored
a de novo heterozygous 1 bp deletion in the penultimate, 2016
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Figure 2. Robinow-Associated DVL3 Variants
Overview of the variants identified in DVL3 in individuals with autosomal-dominant Robinow syndrome.
(A) Location of the identified variants within the final two exons, including three frameshifts in coding regions and two splice acceptor
variants. The red bar within exon 15 represents the shared premature termination codon of all individuals within our cohort.
(B) Representation of the predicted mutant C-terminal tail from Robinow-syndrome-affected individuals in our cohort. Black regions
represent amino acids encoded by exons of the wild-typeDVL3. Red regions representmutant amino acids predicted to result from trans-
lation in the 1 frame.exon ofDVL1: c.1522delC (p.Pro508Leufs*141) (GenBank:
NM_004421.2). To exclude the presence of this variant
in other family members, we used standard PCR amp-
lification. DVL1 primer sequences consisted of 50-GGG
GAAGGGCAGGTAGGG-30 (forward) and 50-CAGTGAGT
GGGGGCTTCG-30 (reverse). Amplified PCR products were
purified with ExoSAP-IT (Affymetrix) and sequenced with
di-deoxynucleotide Sanger sequencing at the DNA
Sequencing and Gene Vector Core at Baylor College of
Medicine. Themutant allelewas not observed in any family
members, including the unaffected brother (BAB8065),
unaffected mother (BAB8063), and unaffected father
(BAB8064). In accordance with our previous observations
for DVL1-mediated Robinow syndrome, this variant is
located in thepenultimate exonand is predicted togenerate
a premature termination codon within the last exon.
Figure 1 demonstrates the surprisingly uniform distribu-
tion of all previously reported DVL1 variants found in sub-
jects from four continents, including the variant identified
in the Turkish subject (BAB8062) reported herein. Concep-
tual translation of the mutant allele in BAB8062 predicts
that the variant will escape NMD and generate a C-termi-
nally truncated protein from the 1 reading frame. The
mutant allele is predicted to encounter a stop codon after
the creation of a highly basic, proline-richmutant C-termi-
nal tail consisting of 140 amino acids while truncating theThe Amefinal 23 C-terminal amino acids. The presence of both
mutant and wild-type mRNA in the lymphoblastoid cells
from BAB8062 supports the hypothesis that the DVL1
mutant transcript escapes NMD (Figure 3A). Furthermore,
a TaqMan gene-expression assay of DVL1 confirmed that
the mutant allele’s mRNA is expressed at levels similar to
those in the unaffected parents (Figure 3B). These data
are in agreement with previous reports6,7 and further sup-
port the contention that DVL1 1 frameshift mutations
that escape NMD are an important molecular cause of DRS.
Five individuals contained frameshift variants in DVL3,
including two splice acceptor mutations and three 1 bp de-
letions; all of the identified variants are predicted to result
in a frameshift to the 1 reading frame and a premature
termination codon in the last exon. All identified variants
inDVL3 are represented in Figure 2 according to GenBank:
NM_004423.3. Primers used to amplify the final two exons
of DVL3 were 50-ACCACGGTCTCTCTCATCCA-30 (for-
ward) and 50-AAGACGGACGGATGGAGAGA-30 (reverse).
BAB7990 harbored a frameshift deletion (c.1585delG
[p.Ala529Profs*139]) located in the penultimate exon of
DVL3, similar to the variants observed in DVL1.
BAB4569 and 015902 contained 1 bp deletions located in
the first several nucleotides of the final exon (c.1716delC
[p.Ser573Valfs*95] and c.1749delC [p.Ser583Argfs*85],
respectively). For confirming the resulting mutant readingrican Journal of Human Genetics 98, 553–561, March 3, 2016 555
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Figure 3. mRNA Expression of DVL1 and
DVL3 Transcripts in Robinow Syndrome
(A) Chromatograms display Sanger
sequencing results of cloned cDNA tran-
scripts in BAB8062 (DVL1) and BAB4569
(DVL3). Mutant and reference alleles
were cloned and sequenced independently
for confirming mutant mRNA expression.
(B) Depiction of the relative change in
gene expression according to a TaqMan
gene-expression assay for DVL1 and
DVL3 with exon-spanning probes
Hs00737028_m1 and Hs00610263_m1,
respectively. For evaluating relative expres-
sion, the DDct method19 was used with
TBP as the endogenous control and unaf-
fected individual BAB8063 as the control
subject.frame, the frameshift deletions in BAB7990 and BAB4569
were manually cloned, and both alleles were sequenced
independently. BAB4569 had previously undergone
whole-exome sequencing as part of the Baylor-Hopkins
Center for Mendelian Genomics initiative, but heteroge-
neous coverage, presumably due to poor capture resulting
from high GC content of the region, prevented identifica-
tion of this variant allele in our analytical informatics pipe-
line. Similar to those of DVL1, both mutant and wild-type
transcripts of DVL3 were expressed (Figure 3A) in carrier
lymphoblastoid cell lines (BAB4569). In addition, DVL3
didnot showalteredmRNAexpression (Figure3B). In aggre-
gate, our data support the prediction that DVL3 mutants
escape NMD. Additionally, individuals BAB7982 and
BAB7985 contained single-nucleotide variants (SNVs) in
the canonical splice acceptor site of the final exon
(c.17151G>A and c.17152A>G, respectively). In silico
prediction of the splice-altering SNVs by the Human
Splicing Finder20 web tool predicts the activation of a556 The American Journal of Human Genetics 98, 553–561, March 3, 2016cryptic splice acceptor site 2 bp down-
stream of the canonical splice
acceptor site in both mutant tran-
scripts.Activationof this cryptic splice
site would result in the use of the 1
frame, which is predicted to create a
mutant protein product similarly to
all the observed DVL3 variants re-
ported herein. None of the described
variants are reported in the 1000
Genomes Project, NHLBI Exome
Sequencing Project, dbSNP, the
Atherosclerosis Risk in Communities
database of ~4,000 individuals, or
our in-house database of >4,200
exomes, which include more than
600 individuals of Turkish ancestry.
The identified Robinow-associated
variants are not present in the Exome
Aggregation Consortium (ExAC)Browser. However, analysis of the ExAC Browser indicated
that threedistinct frameshift indels are located in the30 cod-
ing region ofDVL3 and are predicted to escapeNMD. Those
variants have not been confirmed by Sanger sequencing.
Furthermore, none of the alleles in the ExACBrowser create
a protein product identical to those identified in our study.
Detailed clinical information was available for four sub-
jects with Robinow syndrome due to DVL3 frameshift
alleles. The clinical phenotype of individuals harboring
DVL3 mutations is similar to that of individuals with
DVL1 mutations and concordant with earlier clinical
descriptions of DRS (Table 1, Figure 4, Table S1; see Supple-
mental Data for detailed clinical descriptions).21 Macroce-
phaly was found in two of four individuals with DVL3
mutations and therefore cannot be used to distinguish
betweenDVL1- andDVL3-mediated formsofRobinowsyn-
drome. Curiously, two out of four individuals had telecan-
thus noted instead of true hypertelorism. Congenital heart
defects andcleft lip and/orcleft palate,whichcanbeamajor
Table 1. Clinical Features of Individuals with DVL3-Mediated Robinow Syndrome
Individualsa
BAB7990 BAB7982 BAB4569 015902
Current age 14 years 12 years 35 years 38 years
Age at last examination 10 years 19 months 33 years 27 years
Genotype c.1585delG c.17151G>A c.1716delC c.1749delC
De novo affected father þ þ affected mother
Gender female male female female
Growth Features
Height percentile <3rd <3rd <3rd <3rd
Head-circumference percentile 50th–75th 50th >98th >98th
Facial Features
Frontal bossing  þ  þ
High forehead  þ  
Midface hypoplasia þ þ þ þ
Hypertelorism þ þ  
Telecanthus   þ þ
Upslanting palpebral fissures þ þ  þ
Long eyelashes þ þ  
Prominent eyes þ þ þ 
Blue sclerae þ ND þ 
Epicanthal folds  ND þ 
Anteverted nares þ þ þ þ
Wide, low nasal bridge þ þ not low þ
Short nose þ þ þ þ
Long philtrum þ  þ þ
Triangular mouth   þ 
Thin upper lip    
Gingival hyperplasia þ ND þ þ
Absent uvula    
Cleft lip and/or palate cleft palate cleft lip and palate cleft palate 
Bilobed tongue þ and short ND þ þ
Dental anomalies misaligned ND missing missing
Short neck    webbed
Micrognathia þ þ þ 
Abnormally shaped or positioned ears  low set  
Skeletal Features
Mesomelia þ þ þ þ
Brachydactyly þ þ þ þ
Clinodactyly þ þ þ þ
Syndactyly þ   
Camptodactyly þ   
Broad thumb þ   
(Continued on next page)
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Table 1. Continued
Individualsa
BAB7990 BAB7982 BAB4569 015902
Nail dysplasia    
Bifid first and second phalanges þ   
Hypoplastic phalanges þ þ (fifth)  
Broad first toe þ   þ
Scoliosis or kyphosis þ  þ 
Pectus anomaly þ ND þ 
Urogenital Features
Sacral dimple þ   
Cryptorchidism NA þ NA NA
Hypospadias NA  NA NA
Micropenis NA buried NA NA
Agenesis of the labia minora  NA  
Small clitoris þ NA  
Urinary reflux þ   
Inguinal hernia    
Heart defects VSD, PA, HRH PDA, PFO, TR VSD 
Umbilical hernia    þ
Seizures    
Hearing loss   þ 
Omphalocele þ   
Hepatomegaly    
Abbreviations are as follows: þ, present; , absent; NA, not applicable; ND, no data; PA, pulmonary atresia; HRH, hypoplastic right heart; PDA, patent ductus
arteriosus; PFO, patent foramen ovale; TR, tricuspid regurgitation; and VSD, ventricular septal defect.
aClinical data were not available for subject BAB7985.clinical-management concern at birth, were observed in
three out of four individuals. It is noteworthy that all indi-
viduals with DVL3 mutations have short stature, whereas
individuals with DVL1 mutations have a final stature in
the low-normal range.7 None of the individuals with
DVL3 variants have been reported to have osteosclerosis,
but no specific investigation was conducted to exclude it.
Dishevelled (dsh), originally discovered in Drosophila
melanogaster, is necessary for tissue patterning. Drosophila
dsh has evolved three mammalian orthologs: the homolo-
gous genes DVL1, DVL2, and DVL3. Our data support the
growing evidence that fly genes with greater than one
human homolog are more likely to be associated with hu-
man Mendelian diseases than are fly genes with a single
human homolog, indicating possible specialization during
evolution.22 In mice, DVL1 and DVL3 co-localize within
the developing neural tube, and all three DVL proteins
have similar localization patterns.23 Whereas Dvl1/
mice have a mild phenotype including social abnormal-
ities, Dvl2/ and Dvl3/ mice independently demon-
strate partial lethality and conotruncal defects. Double
knockout of either Dvl1 and Dvl2 or Dvl2 and Dvl3 results558 The American Journal of Human Genetics 98, 553–561, March 3in neural-tube defects, suggesting redundant roles between
the DVL homologs.24 However, Dvl1/Dvl3/ mice do
not display neural-tube defects, indicating functional
divergence between the DVL homologs;24,25 one study
has estimated that DVL2 contributes more than 95% of
the total DVL pool in several mouse cell types.26
Our data strongly support previous studies reporting
that specific 1 frameshift variants in the penultimate
exon of DVL1 cause autosomal-dominant Robinow syn-
drome. The current literature available on DVL1-mediated
Robinow syndrome indicates that these variants are highly
specific and tightly cluster in the penultimate exon and
lead to amutant C-terminal peptide tail that is highly basic
and proline rich (Figure 1). Our data from a subject of Turk-
ish origin, with the same clinically recognizable specific
diagnosis of Robinow syndrome, further support the
notion that DVL1-mediated Robinow syndrome is a
product of the mutant C-terminal tail, a direct result
of 1 frameshift variants, and causes the mutant DVL1
to act in a dominant-negative or gain-of-function manner.
As a result of the high similarity among paralogous
DVLs, DVL1, DVL2, and DVL3 in mice and humans have, 2016
015902
BAB4569
BAB7990
BAB7982
BAB8062
Figure 4. Facial Features of the Individuals with DRS in This
Study
Individuals BAB4569, BAB7982, BAB7990, and 015902 haveDVL3
variants, and BAB8062 has a de novo variant in DVL1.been proposed to have functional redundancy.24,27,28 All
variants observed thus far to underly DVL-mediated
Robinow syndrome result in a mutant C-terminal tail,
the presence of which most likely alters protein folding,
potentially affecting numerous C-terminal phosphoryla-
tion sites and obstructing C-terminal interactors. The three
DVL homologs are capable of forming large dynamic mul-
tiprotein complexes observed as cellular puncta,14 and
these self-associated forms of DVL are critical for its role
in signaling the canonical pathway.15 The self-associated
DVL puncta can be dispersed by the hyperphosphoryla-
tion of DVL. Casein kinase 1ε (CK1ε) is the major kinase
responsible for Wnt-induced DVL3 phosphorylation.29
Interestingly, the hyperphosphorylation of DVL3 requiresThe AmeC-terminal serine clusters, the absence of which alters the
DVL3 subcellular localization and DVL polymerization.29
It is possible that the C termini of DVLs have an ability
to suppress canonical Wnt-b-catenin signaling and
promote non-canonical Wnt transduction. Therefore,
DVL-mediated Robinow syndromemight be a result of spe-
cific mutations that affect the phosphorylation of the
C-terminal tails of DVL1 and DVL3. Further evidence of
this is supported by the interaction between phosphory-
lated DVL3 and the non-canonical Wnt receptor ROR2.30
Stimulated by the hyperphosphorylation of DVL3 by
CK1ε, ROR2 has been shown to interact with DVL3. Inter-
estingly, the DVL3-ROR2 interaction is dependent on the
DVL C terminus, which is lost in all observed DVLmutants
we have identified thus far.31 Curiously, a DVL1 truncated
allele was observed to increase canonical signaling only
when co-expressed in an equal ratio with the wild-type
DVL16 in vitro, perhaps indicating a dominant-negative
interaction given the regulated stoichiometry between
the homologs of DVL within the large signaling complex
and its dynamic polymerization, which might be partially
regulated by ROR2.30 Further work is necessary to elucidate
themechanism by which these specificmutations inDVL1
and DVL3 result in DRS and their interactions within the
global Wnt signalosome.
We conclude that Sanger sequencing of the penultimate
and final exons of DVL1 and DVL3 in individuals with a
suspected diagnosis of autosomal-dominant Robinow syn-
drome is a prudent means for potentially establishing a
molecular diagnosis. In addition to identifying truncating
variants inDVL3 as a cause of Robinow syndrome, we have
shown that these parallel the distinct 1 frameshift muta-
tional mechanism elucidated in DVL1-mediated Robinow
syndrome. Additionally we have shown that the pheno-
typic features of DVL1- and DVL3-mediated Robinow syn-
drome are largely concordant, but possible distinguishing
features include head circumference and stature. Clinical
investigations of subjects with Robinow syndrome are
required for exploring the associated increased bone min-
eral density and the potential underlying Wnt-signaling
differences related to bone mineralization.Accession Numbers
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